Axon wrapped up what should be its 13th consecutive year of top-line growth north of 19%. The stock was a big gainer during the last January when a new president was inaugurated. Axon isn't cheap, but ...

Stanley Black & Decker, Inc. SWK is poised to benefit from its cost-reduction program, which is expected to aid the bottom ...

The stock has had a phenomenal run over the last few years, but Arya's price target of $190 implies 35% upside for the shares ...

The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...